Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07264634
A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)
Sponsor: Ascendis Pharma A/S
View on ClinicalTrials.gov
Summary
This is an observational, opportunistic lactation study to be conducted in lactating female participants who are currently receiving therapeutic doses of YORVIPATH as part of their usual care and who have chosen to breastfeed their infant(s). The potential transfer of palopegteriparatide into breast milk will be assessed.
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
OBSERVATIONAL
Enrollment
10
Start Date
2026-01
Completion Date
2028-01
Last Updated
2025-12-04
Healthy Volunteers
No
Conditions
Interventions
DRUG
Palopegteriparatide
Palopegteriparatide prescribed as per normal clinical practice